Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI helps surgeons remove early cancers more precisely

NCT ID NCT07392268

Recruiting now Knowledge-focused Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new AI system (AI-ENDO) that helps doctors perform a type of keyhole surgery called endoscopic submucosal dissection (ESD) for early-stage cancers in the food pipe, stomach, or bowel. The AI works in the background at first, then provides real-time guidance on a separate screen. The goal is to see if the AI makes the surgery safer and more successful. About 60 adults with these early lesions will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUPERFICIAL ESOPHAGEAL, GASTRIC OR COLORECTAL LESIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

microinvasive gastric cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUPERFICIAL ESOPHAGEAL, GASTRIC OR COLORECTAL LESIONS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong

    RECRUITING

    Hong Kong, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••